相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Delayed spironolactone administration prevents the transition from acute kidney injury to chronic kidney disease through improving renal inflammation
Jonatan Barrera-Chimal et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
Mineralocorticoid receptor negatively regulates angiogenesis through repression of STAT3 activity in endothelial cells
Xiao-Jun Zheng et al.
JOURNAL OF PATHOLOGY (2019)
Safety and efficacy of orally administered telmisartan for the treatment of systemic hypertension in cats: Results of a double-blind, placebo-controlled, randomized clinical trial
Amanda E. Coleman et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2019)
The renin-angiotensin-aldosterone system and its suppression
Marisa K. Ames et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2019)
Chronic Renal Changes After a Single Ischemic Event in an Experimental Model of Feline Chronic Kidney Disease
Cathy A. Brown et al.
VETERINARY PATHOLOGY (2019)
A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients
Fabian Hammer et al.
KIDNEY INTERNATIONAL (2019)
Efficacy of long-term oral telmisartan treatment in cats with hypertension: Results of a prospective European clinical trial
Tony M. Glaus et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2019)
Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial
David M. Charytan et al.
KIDNEY INTERNATIONAL (2019)
Independent regulation of renin-angiotensin-aldosterone system in the kidney
Akira Nishiyama et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2018)
Short- and long-term administration of the non-steroidal mineralocorticoid receptor antagonist finerenone opposes metabolic syndrome-related cardio-renal dysfunction
Marianne Lachaux et al.
DIABETES OBESITY & METABOLISM (2018)
Mineralocorticoid receptor antagonism improves diastolic dysfunction in chronic kidney disease in mice
Benjamin Bonnard et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)
Prognostic importance of plasma total magnesium in a cohort of cats with azotemic chronic kidney disease
D. Hendrik N. van den Broek et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2018)
RNA sequencing of kidney distal tubule cells reveals multiple mediators of chronic aldosterone action
Soren Brandt Poulsen et al.
PHYSIOLOGICAL GENOMICS (2018)
Preclinical pharmacology of AZD9977: A novel mineralocorticoid receptor modulator separating organ protection from effects on electrolyte excretion
Krister Bamberg et al.
PLOS ONE (2018)
Endothelial mineralocorticoid receptor ablation does not alter blood pressure, kidney function or renal vessel contractility
Sidsel B. Laursen et al.
PLOS ONE (2018)
The SEISICAT study: a pilot study assessing efficacy and safety of spironolactone in cats with congestive heart failure secondary to cardiomyopathy
Rachel James et al.
JOURNAL OF VETERINARY CARDIOLOGY (2018)
The eNOS-NO pathway attenuates kidney dysfunction via suppression of inflammasome activation in aldosterone-induced renal injury model mice
Yuji Sogawa et al.
PLOS ONE (2018)
Evaluation of the inhibitory effects of telmisartan on drug-induced renin-angiotensin-aldosterone system activation in normal dogs
M. Konta et al.
JOURNAL OF VETERINARY CARDIOLOGY (2018)
ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats
Mark J. Acierno et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2018)
Genomic and rapid effects of aldosterone: what we know and do not know thus far
Milla Marques Hermidorff et al.
HEART FAILURE REVIEWS (2017)
Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Protects Against Acute Kidney Injury-Mediated Chronic Kidney Disease Role of Oxidative Stress
Lionel Lattenist et al.
HYPERTENSION (2017)
Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease
M. K. Ames et al.
JOURNAL OF VETERINARY CARDIOLOGY (2017)
Randomized Controlled Trial of Mineralocorticoid Receptor Blockade in Children with Chronic Kidney Allograft Nephropathy
Mara Medeiros et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Sulfenic Acid Modification of Endothelin B Receptor is Responsible for the Benefit of a Nonsteroidal Mineralocorticoid Receptor Antagonist in Renal Ischemia
Jonatan Barrera-Chimal et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Unilateral Renal Ischemia as a Model of Acute Kidney Injury and Renal Fibrosis in Cats
C. W. Schmiedt et al.
VETERINARY PATHOLOGY (2016)
The Safety and Efficacy of Mineralocorticoid Receptor Antagonists in Patients Who Require Dialysis: A Systematic Review and Meta-analysis
Kevin Quach et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Up-regulation of FGF23 release by aldosterone
Bingbing Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Epidermal growth factor receptor signaling mediates aldosterone-induced profibrotic responses in kidney
Lili Sheng et al.
EXPERIMENTAL CELL RESEARCH (2016)
Risk Factors for Development of Chronic Kidney Disease in Cats
N. C. Finch et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2016)
Deletion of mineralocorticoid receptors in smooth muscle cells blunts renal vascular resistance following acute cyclosporine administration
Cristian A. Amador et al.
KIDNEY INTERNATIONAL (2016)
Current Understanding of the Pathogenesis of Progressive Chronic Kidney Disease in Cats
Rosanne E. Jepson
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2016)
Is Progressive Chronic Kidney Disease a Slow Acute Kidney Injury?
Larry D. Cowgill et al.
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2016)
Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis
Gemma Currie et al.
BMC NEPHROLOGY (2016)
Aldosterone Induces Renal Fibrosis and Inflammatory M1-Macrophage Subtype via Mineralocorticoid Receptor in Rats
Beatriz Martin-Fernandez et al.
PLOS ONE (2016)
Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology
F. Jaisser et al.
PHARMACOLOGICAL REVIEWS (2016)
Effects of high doses of enalapril and benazepril on the pharmacologically activated renin-angiotensin-aldosterone system in clinically normal dogs
Marisa K. Ames et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2015)
Spironolactone Add-on for Preventing or Slowing the Progression of Diabetic Nephropathy: A Meta-analysis
Jing Hou et al.
CLINICAL THERAPEUTICS (2015)
Nonsteroidal antagonists of the mineralocorticoid receptor
Peter Kolkhof et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2015)
Excess aldosterone is a critical danger signal for inflammasome activation in the development of renal fibrosis in mice
Hiroyuki Kadoya et al.
FASEB JOURNAL (2015)
Mild ischemic Injury Leads to Long-Term Alterations in the Kidney: Amelioration by Spironolactone Administration
Jonatan Barrera-Chimal et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2015)
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy A Randomized Clinical Trial
George L. Bakris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Comparison of Efficacy of Long-term Oral Treatment with Telmisartan and Benazepril in Cats with Chronic Kidney Disease
U. Sent et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2015)
Relationship between Plasma Fibroblast Growth Factor-23 Concentration and Survival Time in Cats with Chronic Kidney Disease
R. F. Geddes et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2015)
Longevity and mortality of cats attending primary care veterinary practices in England
Dan G. O'Neill et al.
JOURNAL OF FELINE MEDICINE AND SURGERY (2015)
Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-Analysis
Hiddo J. Lambers Heerspink et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Aldosterone breakthrough with benazepril in furosemide-activated renin-angiotensin-aldosterone system in normal dogs
A. C. Lantis et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2015)
A Comparison of Biochemical and Histopathologic Staging in Cats With Chronic Kidney Disease
S. M. McLeland et al.
VETERINARY PATHOLOGY (2015)
Mineralocorticoid Receptor Activation and Mineralocorticoid Receptor Antagonist Treatment in Cardiac and Renal Diseases
Johann Bauersachs et al.
HYPERTENSION (2015)
Circulating Aldosterone and Natriuretic Peptides in the General Community Relationship to Cardiorenal and Metabolic Disease
Alessia Buglioni et al.
HYPERTENSION (2015)
Aldosterone Dysregulation With Aging Predicts Renal Vascular Function and Cardiovascular Risk
Jenifer M. Brown et al.
HYPERTENSION (2014)
Risk factors associated with the development of chronic kidney disease in cats evaluated at primary care veterinary hospitals
Joseph P. Greene et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2014)
Pretreatment with mineralocorticoid receptor blocker reduces intestinal injury induced by ischemia and reperfusion: involvement of inhibition of inflammatory response, oxidative stress, nuclear factor κB, and inducible nitric oxide synthase
Hale Sayan Ozacmak et al.
JOURNAL OF SURGICAL RESEARCH (2014)
Spironolactone Reduces Cardiovascular and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients
Yoshihiro Matsumoto et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Plasma Renin Activity and Aldosterone Concentrations in Hypertensive Cats with and without Azotemia and in Response to Treatment with Amlodipine Besylate
R. E. Jepson et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2014)
Intrarenal Distributions and Changes of Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 in Feline and Canine Chronic Kidney Disease
Sawane Mitani et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2014)
Mineralocorticoid receptors in immune cells: Emerging role in cardiovascular disease
Nicholas C. Bene et al.
STEROIDS (2014)
Renal Morphology in Cats With Diabetes Mellitus
E. Zini et al.
VETERINARY PATHOLOGY (2014)
Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial
Katsuyuki Ando et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Mineralocorticoid Receptor Blockade Reduced Oxidative Stress in Renal Transplant Recipients: A Double-Blind, Randomized Pilot Study
Marcos Ojeda-Cervantes et al.
AMERICAN JOURNAL OF NEPHROLOGY (2013)
Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation
Robert Gros et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2013)
Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
Bertram Pitt et al.
EUROPEAN HEART JOURNAL (2013)
Regulation of aldosterone secretion: from physiology to disease
Felix Beuschlein
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry
Aldo P. Maggioni et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Blood pressure has only minor influence on aldosterone-induced oxidative stress and DNA damage in vivo
Nina Queisser et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Aldosterone stimulates fibronectin synthesis in renal fibroblasts through mineralocorticoid receptor-dependent and independent mechanisms
Dong Chen et al.
GENE (2013)
Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function Analyses of the EMPHASIS-HF Study Subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)
Romain Eschalier et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Safety of Spironolactone in Dogs with Chronic Heart Failure because of Degenerative Valvular Disease: A Population-Based, Longitudinal Study
H. P. Lefebvre et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2013)
Association between the Intrarenal Renin-Angiotensin System and Renal Injury in Chronic Kidney Disease of Dogs and Cats
Sawane Mitani et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2013)
Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury
Jonatan Barrera-Chimal et al.
KIDNEY INTERNATIONAL (2013)
Chronic kidney disease: global dimension and perspectives
Vivekanand Jha et al.
LANCET (2013)
Long-term effects of addition of mineralocorticoid receptor antagonist to angiotensin II receptor blocker in patients with diabetic nephropathy: a randomized clinical trial
Alireza Esteghamati et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Eplerenone Attenuates Pulse Wave Reflection in Chronic Kidney Disease Stage 3-4-A Randomized Controlled Study
Lene Boesby et al.
PLOS ONE (2013)
Histomorphometry of Feline Chronic Kidney Disease and Correlation With Markers of Renal Dysfunction
S. Chakrabarti et al.
VETERINARY PATHOLOGY (2013)
Aldosterone stimulates nuclear factor-kappa B activity and transcription of intercellular adhesion molecule-1 and connective tissue growth factor in rat mesangial cells via serum- and glucocorticoid-inducible protein kinase-1
Yoshio Terada et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2012)
Mineralocorticoid Receptor Blocker Eplerenone Improves Endothelial Function and Inhibits Rho-Associated Kinase Activity in Patients With Hypertension
N. Fujimura et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease
R. Pisoni et al.
JOURNAL OF HUMAN HYPERTENSION (2012)
Plasma renin activity and the aldosterone-to-renin ratio are associated with the development of chronic kidney disease: the Ohasama Study
Shiho Terata et al.
JOURNAL OF HYPERTENSION (2012)
Clinicopathological Variables Predicting Progression of Azotemia in Cats with Chronic Kidney Disease
S. Chakrabarti et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2012)
Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms
Linda Shavit et al.
KIDNEY INTERNATIONAL (2012)
Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury
James M. Luther et al.
KIDNEY INTERNATIONAL (2012)
Tissue-specific modulation of mineralocorticoid receptor function by 11β-hydroxysteroid dehydrogenases: An overview
Alex Odermatt et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Molecular pharmacology of the mineralocorticoid receptor: Prospects for novel therapeutics
Peter Kolkhof et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Recovery from ischemic acute kidney injury by spironolactone administration
Katy Sanchez-Pozos et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Aldosterone Induces Kidney Fibroblast Proliferation via Activation of Growth Factor Receptors and PI3K/MAPK Signalling
L. L. Huang et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2012)
Oxidative Stress-Induced Glomerular Mineralocorticoid Receptor Activation Limits the Benefit of Salt Reduction in Dahl Salt-Sensitive Rats
Kento Kitada et al.
PLOS ONE (2012)
Bilateral renal ischemia as a model of acute kidney injury in cats
C. W. Schmiedt et al.
RESEARCH IN VETERINARY SCIENCE (2012)
The Attributable Burden of Hypertension: Focus on CKD
Kenneth A. Jamerson et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2011)
Plasma aldosterone levels and aldosterone-to-renin ratios are associated with endothelial dysfunction in young to middle-aged subjects
A. Hannemann et al.
ATHEROSCLEROSIS (2011)
Chronic Antagonism of the Mineralocorticoid Receptor Ameliorates Hypertension and End Organ Damage in a Rodent Model of Salt-Sensitive Hypertension
Xiaoyan Zhou et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2011)
Pathophysiological Roles of Aldosterone and Mineralocorticoid Receptor in the Kidney
Kazi Rafiq et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2011)
Study of the mechanisms of aldosterone prothrombotic effect in rats
Anna Gromotowicz et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2011)
Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease
Jean-Philippe Bertocchio et al.
KIDNEY INTERNATIONAL (2011)
Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production
Jiro Toyonaga et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Osteopontin deficiency protects against aldosterone-induced inflammation, oxidative stress, and interstitial fibrosis in the kidney
Jun Irita et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Effect of Spironolactone on Left Ventricular Systolic and Diastolic Function in Patients With Early Stage Chronic Kidney Disease
Nicola C. Edwards et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Effect of Eplerenone on Endothelial Progenitor Cells and Oxidative Stress in Ischemic Hindlimb
Naohiko Kobayashi et al.
AMERICAN JOURNAL OF HYPERTENSION (2010)
Role of the Intrarenal Renin-Angiotensin-Aldosterone System in Chronic Kidney Disease
Helmy M. Siragy et al.
AMERICAN JOURNAL OF NEPHROLOGY (2010)
Mechanism of endothelial dysfunction in chronic kidney disease
Jolanta Malyszko
CLINICA CHIMICA ACTA (2010)
A Randomized, Double-Blind, Placebo-Controlled Trial of Spironolactone on Carotid Intima-Media Thickness in Nondiabetic Hemodialysis Patients
Antonio Vukusich et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure
Aurelie Nguyen Dinh Cat et al.
FASEB JOURNAL (2010)
Aldosterone Causes DNA Strand Breaks and Chromosomal Damage in Renal Cells, Which are Prevented by Mineralocorticoid Receptor Antagonists
N. Schupp et al.
HORMONE AND METABOLIC RESEARCH (2010)
Mineralocorticoid Receptor Blockade Enhances the Antiproteinuric Effect of an Angiotensin II Blocker through Inhibiting Podocyte Injury in Type 2 Diabetic Rats
Akira Nishiyama et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
A preclinical pharmacokinetic and pharmacodynamic approach to determine a dose of spironolactone for treatment of congestive heart failure in dog
J. Guyonnet et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2010)
Comparative study of chronic kidney disease in dogs and cats: Induction of myofibroblasts
A. Yabuki et al.
RESEARCH IN VETERINARY SCIENCE (2010)
The Serum and Glucocorticoid-Regulated Kinase 1 in Hypoxic Renal Injury
Krisztina Rusai et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2009)
Glucocorticoids Activate Cardiac Mineralocorticoid Receptors During Experimental Myocardial Infarction
Anastasia S. Mihailidou et al.
HYPERTENSION (2009)
Aldosterone Increases Oxidant Stress to Impair Guanylyl Cyclase Activity by Cysteinyl Thiol Oxidation in Vascular Smooth Muscle Cells
Bradley A. Maron et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Urinary cortisol/cortisone ratios in hypertensive and normotensive cats
David J. Walker et al.
JOURNAL OF FELINE MEDICINE AND SURGERY (2009)
Effect of Spironolactone on Left Ventricular Mass and Aortic Stiffness in Early-Stage Chronic Kidney Disease A Randomized Controlled Trial
Nicola C. Edwards et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Evaluation of Predictors of the Development of Azotemia in Cats
R. E. Jepson et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2009)
Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats
Young Sun Kang et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Antifibrotic Effects of Aldosterone Receptor Blocker (Spironolactone) in Patients with Chronic Kidney Disease
Ibrahim Guney et al.
RENAL FAILURE (2009)
Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions
Sun Ha Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Adrenalectomy prevents renal ischemia-reperfusion injury
Victoria Ramirez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats
Jun Du et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Spironolactone ameliorates transplant vasculopathy in renal chronic transplant dysfunction in rats
Femke Waanders et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Change in proteinuria after adding aldosterone Blockers to ACE inhibitors or angiotensin receptor Blockers in CKD: A systematic review
Andrew S. Bomback et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: An open-label crossover randomized controlled trial
Leszek Tylicki et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion
Massimiliano Caprio et al.
CIRCULATION RESEARCH (2008)
The role of mineralocorticoid receptor expression in brain remodeling after cerebral ischemia
Naofumi Oyamada et al.
ENDOCRINOLOGY (2008)
Aldosterone induces myofibroblastic transdifferentiation and collagen gene expression through the Rho-kinase dependent signaling pathway in rat mesangial cells
Suwarni Diah et al.
EXPERIMENTAL CELL RESEARCH (2008)
Osteopontin in rat renal fibroblasts functional properties and transcriptional regulation by aldosterone
Jun Irita et al.
HYPERTENSION (2008)
Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and prevents oxidative stress in uremic rats
Luis Michea et al.
HYPERTENSION (2008)
Survival in cats with naturally occurring chronic kidney disease (2000-2002)
L. M. Boyd et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2008)
Plasma asymmetric dimethylarginine, symmetric dimethylarginine, L-arginine, and nitrite/nitrate concentrations in cats with chronic kidney disease and hypertension
R. E. Jepson et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2008)
Effect of spironolactone on diastolic function and left ventricular mass in maine coon cats with familial hypertrophic cardiomyopathy
K. A. MacDonald et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2008)
Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease
Shigeru Shibata et al.
NATURE MEDICINE (2008)
Inhibition of mineralocorticoid receptors with eplerenone alleviates short-term cyclosporin A nephrotoxicity in conscious rats
Finn Thomsen Nielsen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Chronic hypoxia aggravates renal injury via suppression of Cu/Zn-SOD: a proteomic analysis
Daisuke Son et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor - Role of oxidative stress
Miki Nagase et al.
HYPERTENSION (2007)
Effects of benazepril hydrochloride in cats with experimentally induced or spontaneously occurring chronic renal failure
Toshifumi Watanabe et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2007)
Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin
Aihua Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone
Norma A. Bobadilla et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone
Juan M. Mejia-Vilet et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Relationships of plasma renin levels with renal function in patients with primary aldosteronism
Cristiana Catena et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone rats
Christine' S. Rigsby et al.
MICROVASCULAR RESEARCH (2007)
Measurement of aldosterone in feline, canine and human urine
H. M. Syme et al.
JOURNAL OF SMALL ANIMAL PRACTICE (2007)
Podocyte as the target for aldosterone - Roles of oxidative stress and Sgk1
Shigeru Shibata et al.
HYPERTENSION (2007)
Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity
Jane A. Leopold et al.
NATURE MEDICINE (2007)
Rapid effects of aldosterone on clonal human vascular smooth muscle cells
Robert Gros et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity
Jazmin Perez-Rojas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease
S. Bianchi et al.
KIDNEY INTERNATIONAL (2006)
Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: Possible contribution of fat-derived factors
Miki Nagase et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus
Christine Guo et al.
ENDOCRINOLOGY (2006)
Clinical evaluation of dietary modification for treatment of spontaneous chronic kidney disease in cats
Sheri J. Ross et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2006)
Aldosterone promotes fibronectin production through a Smad2-dependent TGF-β1 pathway in mesangial cells
Lingyun Lai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes
Murray Epstein et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Involvements of rho-kinase and TGF-β pathways in aldosterone-induced renal injury
Guang-Ping Sun et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Association of laboratory data and death within one month in cats with chronic renal failure
Y. Kuwahara et al.
JOURNAL OF SMALL ANIMAL PRACTICE (2006)
Aldosterone antagonism in chronic kidney disease
Manish P. Ponda et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity
Daisuke Nagata et al.
HYPERTENSION (2006)
Rapid nongenomic effects of aldosterone on the renal vasculature in humans
BMW Schmidt et al.
HYPERTENSION (2006)
Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker
Anastasia Chrysostomou et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure
Masaomi Nangaku
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy
Kohzo Takebayashi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Molecular mechanisms and therapeutic strategies of chronic renal injury: Renoprotective effects of aldosterone blockade
A Nishiyama et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2006)
Aldosterone blockage in proliferative glomerulonephritis prevents not only fibrosis, but proliferation as well
Mustafa Gullulu et al.
RENAL FAILURE (2006)
Renocortical mRNA expression of vasoactive factors during spironolactone protective effect in chronic cyclosporine nephrotoxicity
JM Pérez-Rojas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Regression of existing glomerulosclerosis by inhibition of aldosterone
JC Aldigier et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts
Y Nagai et al.
HYPERTENSION (2005)
Low-renin hypertension with relative aldosterone excess is associated with impaired NO-mediated vasodilation
SJ Duffy et al.
HYPERTENSION (2005)
Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria
M Quinkler et al.
CIRCULATION (2005)
Eplerenone reduces oxidative stress and enhances eNOS in SHR:: Vascular functional and structural consequences
D Sanz-Rosa et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Aldosterone nongenomically worsens ischemia via protein kinase C-dependent pathways in hypoperfused canine hearts
M Fujita et al.
HYPERTENSION (2005)
Primary hyperaldosteronism in the cat: a series of 13 cases
R Andrew et al.
JOURNAL OF FELINE MEDICINE AND SURGERY (2005)
Population-based drug-induced agranulocytosis
L Ibáñez et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability
A Nishiyama et al.
HYPERTENSION (2005)
SGK1: A rapid aldosterone-induced regulator of renal sodium reabsorption
JA McCormick et al.
PHYSIOLOGY (2005)
Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKCε-MAPK-p90RSK, and rho-kinase pathway
N Kobayashi et al.
HYPERTENSION (2005)
Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells
IZ Jaffe et al.
CIRCULATION RESEARCH (2005)
Eplerenone blocks nongenomic effects of aldosterone on the Na+/H+ exchanger, intracellular Ca2+ levels, and vasoconstriction in mesenteric resistance vessels
L Michea et al.
ENDOCRINOLOGY (2005)
Effects of aldosterone and mineralocorticoid receptor blockade on intracellular electrolytes
M Wehling
HEART FAILURE REVIEWS (2005)
Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis
D Sica
HEART FAILURE REVIEWS (2005)
Primary hyperaldosteronism, a mediator of progressive renal disease in cats
S Javadi et al.
DOMESTIC ANIMAL ENDOCRINOLOGY (2005)
Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor
C Xue et al.
HYPERTENSION (2005)
Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease
A Sato et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats
A Nishiyama et al.
HYPERTENSION (2004)
Aldosterone-induced vasculopathy
AD Struthers
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2004)
Blood pressure assessment in healthy cats and cats with hypertensive retinopathy
J Sansom et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2004)
Endothelium-derived nitric oxide modulates vascular action of aldosterone in renal arteriole
S Arima et al.
HYPERTENSION (2004)
Characterisatioti of 11β-hydroxysteroid dehydrogenases in feline kidney and liver
L Schipper et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2004)
Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats
G Fujisawa et al.
KIDNEY INTERNATIONAL (2004)
Rapid non-genomic effects of aldosterone on rodent vascular function
TR Uhrenholt et al.
ACTA PHYSIOLOGICA SCANDINAVICA (2004)
Spironolactone in combination with cilazapril ameliorates proteinuria and renal interstitial fibrosis in rats with anti-thy-1 irreversible nephritis
M Asai et al.
HYPERTENSION RESEARCH (2004)
Evaluation of a technique of inducing hypertensive renal insufficiency in cats
S Mathur et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2004)
Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment
JE Macdonald et al.
HEART (2004)
Aldosterone in the development and progression of renal injury
NK Hollenberg
KIDNEY INTERNATIONAL (2004)
NO bioavailability, endothelial dysfunction, and acute renal failure: New insights into pathophysiology
MS Goligorsky et al.
SEMINARS IN NEPHROLOGY (2004)
Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism
MK Nishizaka et al.
CIRCULATION (2004)
Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate
KJ Schjoedt et al.
DIABETOLOGIA (2004)
Effects of dietary sodium chloride intake on renal function and blood pressure in cats with normal and reduced renal function
C Buranakarl et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2004)
被撤回的出版物: The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study (Retracted article see vol 23, pg 818, 2006)
R Rachmani et al.
DIABETIC MEDICINE (2004)
Human endothelium:: Target for aldosterone
H Oberleithner et al.
HYPERTENSION (2004)
Aldosterone regulates vascular reactivity - Short-term effects mediated by phosphatidylinositol 3-kinase-dependent nitric oxide synthase activation
SL Liu et al.
CIRCULATION (2003)
Aldosterone stimulates epidermal growth factor receptor expression
AW Krug et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Early transcriptional effects of aldosterone in a mouse inner medullary collecting duct cell line
ML Gumz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2003)
Nongenomic vascular action of aldosterone in the glomerular microcirculation
S Arima et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling
Q Pu et al.
HYPERTENSION (2003)
Aldosterone: Direct effects on and production by the heart
PC White
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension
WB White et al.
HYPERTENSION (2003)
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats
ER Blasi et al.
KIDNEY INTERNATIONAL (2003)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Effectiveness of aldosterone blockade in patients with diabetic nephropathy
A Sato et al.
HYPERTENSION (2003)
Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity
I Feria et al.
KIDNEY INTERNATIONAL (2003)
Aldosterone-induced inflammation in the rat heart - Role of oxidative stress
Y Sun et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Spironolactone improves angiotensin-induced vascular changes and oxidative stress
A Virdis et al.
HYPERTENSION (2002)
Aldosterone induces acute endothelial dysfunction in vivo in humans:: evidence for an aldosterone-induced vasculopathy
CAJ Farquharson et al.
CLINICAL SCIENCE (2002)
Prevalence of systolic hypertension in cats with chronic renal failure at initial evaluation
HM Syme et al.
JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2002)
Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease
T Heitzer et al.
CIRCULATION (2001)
Prognostic significance of endothelial dysfunction in hypertensive patients
F Perticone et al.
CIRCULATION (2001)
Effects of the angiotensin converting enzyme inhibitor benazepril in cats with induced renal insufficiency
SA Brown et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2001)
Aldosterone: A mediator of myocardial necrosis and renal arteriopathy
R Rocha et al.
ENDOCRINOLOGY (2000)
Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo
NJ Brown et al.
KIDNEY INTERNATIONAL (2000)
Expression of 11β-hydroxylase and aldosterone synthase genes in the rat brain
SM MacKenzie et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2000)
Survival of cats with naturally occurring chronic renal failure: effect of dietary management
J Elliott et al.
JOURNAL OF SMALL ANIMAL PRACTICE (2000)
Local angiotensin II and transforming growth factor-β1 in renal fibrosis of rats
Y Sun et al.
HYPERTENSION (2000)
Expression of alpha-smooth muscle actin and fibronectin in tubulointerstitial lesions of cats with chronic renal failure
K Sawashima et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2000)
分享论文
